New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 7, 2017 – Prasco launched an authorized generic version of Recordati Rare Diseases’ Cosmegen (dactinomycin) injection.
Download PDF
Return to publications
